Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 332 Records) |
Query Trace: Neoplasms and MTOR[original query] |
---|
Prevalence of PIK3CA mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysis. Frontiers in oncology 2023 9 13 1192946. Ta-Chung Chao, Yi-Fang Tsai, Chun-Yu Liu, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Jiun-I Lai, Chih-Yi Hsu, Jiun Jen Lynn, Chi-Cheng Huang, Ling-Ming Tse |
Remote modulation of WWOX by an intronic variant associated with survival of Chinese gastric cancer patients. International journal of cancer 2023 8 . Lei Cheng, Yuanyuan Chang, Zuguang Xia, Yizhen Liu, Xiao Liu, Liwen Xiong, Chenchen Liu, Xiaodong Zhu, Mengyun Wang, Lixin Q |
[Characteristics of PIK3CA gene mutations in Her2-low breast cancer]. Arkhiv patologii 2023 8 85 (4): 5-11. I A Pavlenko, P E Povilaitite, N S Makarevich, V Yu Kaciyaev, A V Petr |
Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer. Frontiers in pharmacology 2023 7 14 1192434. Jixian Li, Wentao Zhang, Xiaoqing Ma, Yanjun Wei, Fengge Zhou, Jianan Li, Chenggui Zhang, Zhe Ya |
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of ovarian research 2023 7 16 (1): 141. A W Adamson, Y C Ding, L Steele, L A Leong, R Morgan, M T Wakabayashi, E S Han, T H Dellinger, P S Lin, A A Hakim, S Wilczynski, C D Warden, S Tao, V Bedell, M C Cristea, S L Neuhaus |
Diagnostic Potential of Endometrial Cancer DNA from Pipelle, Pap-Brush, and Swab Sampling. Cancers 2023 7 15 (13): . Yinan Wang, Hui Du, Wenkui Dai, Cuijun Bao, Xi Zhang, Yan Hu, Zhiyu Xie, Xin Zhao, Changzhong Li, Wenyong Zhang, Ruifang |
Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. Cancer medicine 2023 6 . Xiaoling Duan, Man Zhao, Xiaolei Yin, Lili Mi, Jianfei Shi, Ning Li, Xin Han, Guangjie Han, Jinfeng Wang, Jiaojiao Hou, Fei Y |
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study. Journal of clinical pathology 2023 6 . Federica Miglietta, Valentina Carraro, Ottavia Amato, Gaia Griguolo, Michele Bottosso, Giada Munari, Giovanni Zarrilli, Marcello Lo Mele, Caterina Barbieri, Angelo Paolo Dei Tos, Valentina Guarneri, Maria Vittoria Dieci, Matteo Fass |
Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia. Haematologica 2023 5 . Almut Lütge, Junyan Lu, Jennifer Hüllein, Tatjana Walther, Leopold Sellner, Bian Wu, Richard Rosenquist, Christopher C Oakes, Sascha Dietrich, Wolfgang Huber, Thorsten Ze |
mTOR pathway candidate genes and energy intake interaction on breast cancer risk in Black women from the Women's Circle of Health Study. European journal of nutrition 2023 5 . Mmadili N Ilozumba, Lusine Yaghjyan, Susmita Datta, Jinying Zhao, Chi-Chen Hong, Kathryn L Lunetta, Gary Zirpoli, Elisa V Bandera, Julie R Palmer, Song Yao, Christine B Ambrosone, Ting-Yuan David Che |
Human Papillomavirus Infection and EGFR Exon 20 Insertions in Sinonasal Inverted Papilloma and Squamous Cell Carcinoma. Journal of personalized medicine 2023 4 13 (4): . Hitoshi Hirakawa, Taro Ikegami, Norimoto Kise, Hidetoshi Kinjyo, Shunsuke Kondo, Shinya Agena, Narumi Hasegawa, Junko Kawakami, Hiroyuki Maeda, Mikio Suzu |
Aberrant serum and tissue levels of Beclin1 and mechanistic target of rapamycin (mTOR) proteins in epithelial ovarian cancer. Medicine 2023 4 102 (17): e33515. Huixia Lu, Hong Hu, Zhihong Yang, Shaobo |
Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways. Scientific reports 2023 4 13 (1): 6681. Leonard M Quinn, Sam Haldenby, Philip Antzcak, Anna Fowler, Katie Bullock, John Kenny, Timothy Gilbert, Timothy Andrews, Rafael Diaz-Nieto, Stephen Fenwick, Robert Jones, Eithne Costello-Goldring, Graeme Poston, William Greenhalf, Daniel Palmer, Hassan Malik, Chris Goldri |
BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials. Cancer immunology, immunotherapy : CII 2023 4 . Liu Kan, Huang Yan, Xu Yu, Wang Guoqiang, Cai Shangli, Zhang Xu, Shi Taopi |
mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women's circle of health study. Breast cancer research and treatment 2023 3 . Ilozumba Mmadili N, Yaghjyan Lusine, Datta Susmita, Zhao Jinying, Gong Zhihong, Hong Chi-Chen, Lunetta Kathryn L, Zirpoli Gary, Bandera Elisa V, Palmer Julie R, Yao Song, Ambrosone Christine B, Cheng Ting-Yuan Dav |
Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer. Research square 2023 3 . Adamson Aaron W, Ding Yuan Chun, Steele Linda, Leong Lucile A, Morgan Robert, Wakabayashi Mark T, Han Ernest S, Dellinger Thanh H, Lin Paul S, Hakim Amy A, Wilczynski Sharon, Warden Charles D, Tao Shu, Bedell Victoria, Cristea Mihaela C, Neuhausen Susan |
TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma. Archives of pathology & laboratory medicine 2023 3 . Webersinke Gerald, Burghofer Jonathan, Malli Theodora, Rammer Melanie, Jahn Stephan Wenzel, Niendorf Axel, Tavassoli Fattaneh A, Moinfar Far |
Relationship Between MUC4 Variants and Metastatic Recurrence in Colorectal Cancer. International journal of general medicine 2023 11 16 5077-5087. Jieqiong Liu, Rongge Xing, Jiakang Shao, Shunchang Ji |
Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing. Medical oncology (Northwood, London, England) 2023 11 40 (12): 349. Shaowen Zhang, Ping Dong, Zongwei Pan, Qian Chen, Junqi Zhu, Zhangfan M |
Characterization of the genomic alterations in poorly differentiated thyroid cancer. Scientific reports 2023 11 13 (1): 19154. Yeeun Lee, SeongRyeol Moon, Jae Yeon Seok, Joon-Hyop Lee, Seungyoon Nam, Yoo Seung Chu |
Genomic Alterations of Signaling and DNA Damage Repair Pathways in Non-Muscle Invasive Bladder Cancer. Cancer investigation 2023 11 1-10. Serdar Celik, Tekincan Aktas, Ozde Gokbayrak, Aylin Erol, Kutsal Yorukoglu, Batuhan Yilmaz, Hilmi Sari, Zekiye Altun, Mehmet Ugur Mungan, Ilhan Celebi, Guven Aslan, Safiye Akt |
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection. International journal of cancer 2023 11 . Abderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet, Jérémie H Lefèvre, Magali Svrcek, Sophie Vacher, Christine Bourneix, Matthieu Delaye, Diane Goéré, Peggy Dartigues, Emmanuelle Samalin, Marc Hilmi, Julien Lazartigues, Elodie Girard, Jean-François Emile, Eugénie Rigault, Virginie Dangles-Marie, Nathalie Rioux-Leclercq, Christelle de la Fouchardière, David Tougeron, Andrea Casadei-Gardini, Pascale Mariani, Frédérique Peschaud, Wulfran Cacheux, Astrid Lièvre, Ivan Bièc |
Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay. Current oncology (Toronto, Ont.) 2023 10 30 (10): 8902-8915. Michael I Koukourakis, Erasmia Xanthopoulou, Ioannis M Koukourakis, Sotirios P Fortis, Nikolaos Kesesidis, Christos Kakouratos, Ioannis Karakasiliotis, Constantin N Baxevan |
Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis. Computers in biology and medicine 2023 10 167 107591. Yin He, Xiaosheng Wa |
miRNA-767 and its binding site polymorphism in the mTOR gene act as potential biomarkers for female reproductive cancers. Future oncology (London, England) 2023 10 19 (28): 1929-1943. Rabia Shafique, Ishrat Mahjabeen, Kashaf Bibi, Farah Kalsoom, Muhammad Rizwan, Nida Sarosh Ashraf, Azhar Mehmood, Maria Fazal Ul Haq, Sumaira Fida Abbasi, Nadia Saeed, Mahmood Akhtar Kaya |
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials. Gynecologic oncology 2024 4 183 103-114. Zachary A Kopelman, Chunqiao Tian, Jordyn Tumas, Neil T Phippen, Christopher M Tarney, Erica R Hope, Stuart S Winkler, Suzanne Jokajtys, Calen W Kucera, John K Chan, Michael T Richardson, Daniel S Kapp, Chad A Hamilton, Charles A Leath, Nathaniel L Jones, Rodney P Rocconi, John H Farley, Angeles Alvarez Secord, Casey M Cosgrove, Matthew A Powell, Ann Klopp, Joan L Walker, Gini F Fleming, Nicholas W Bateman, Thomas P Conrads, G Larry Maxwell, Kathleen M Dar |
Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation. Frontiers in oncology 2024 4 14 1357980. Mariko Peterson, David L Kolin, Panagiotis A Konstantinopoul |
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane. British journal of cancer 2024 1 . Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, Ivan Bieche, Mario Campone, Anne Patsouris, Monica Arnedos, Paul H Cottu, Jean-Philippe Jacquin, Florence Dalenc, Antoine Pinton, Nicolas Servant, Valéry Attignon, Etienne Rouleau, Alain Morel, François Legrand, Marta Jimenez, Fabrice Andre, Thomas Bachel |
Identification of a Novel Germline PPP4R3A Missense Mutation Asp409Asn on Familial Non-Medullary Thyroid Carcinoma. Biomedicines 2024 1 12 (1): . Yixuan Hu, Zhuojun Han, Honghao Guo, Ning Zhang, Na Shen, Yujia Jiang, Tao Hua |
Analysis of HIF-1? expression and genetic polymorphisms in human clear cell renal cell carcinoma. Pathology oncology research : POR 2024 1 29 1611444. Daniela Vargova, Zuzana Kolková, Jan Dargaj, Lukas Bris, Jan Luptak, Zuzana Dankova, Sona Franova, Jan Svihra, Pavol Slávik, Martina Sutovs |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: